Presenter: Manuela Joore PhD
Department of Clinical Epidemiology & Medical Technology Assessment
Maastricht University Medical Center+
The case of trastuzumab for the adjuvant treatment of HER2-positive early breast cancer in the Netherlands
Evaluation resources are scarce. Is it possible to transfer results of model-based economic evaluations across jurisdictions to assist in making market access and reimbursement decisions in a timely fashion?
To develop and use a method to estimate country-specific cost-effectiveness based on a foreign model-based cost-effectiveness study